Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 9/2013

01-09-2013 | Original Article

An Envirogenomic Signature Is Associated with Risk of IBD-Related Surgery in a Population-Based Crohn’s Disease Cohort

Authors: Bushra F Nasir, Lyn R Griffiths, Aslam Nasir, Rebecca Roberts, Murray Barclay, Richard B Gearry, Rodney A Lea

Published in: Journal of Gastrointestinal Surgery | Issue 9/2013

Login to get access

Abstract

Background and Aims

Crohn’s disease (CD) is an inflammatory bowel disease (IBD) caused by a combination of genetic, clinical, and environmental factors. Identification of CD patients at high risk of requiring surgery may assist clinicians to decide on a top–down or step-up treatment approach.

Methods

We conducted a retrospective case–control analysis of a population-based cohort of 503 CD patients. A regression-based data reduction approach was used to systematically analyse 63 genomic, clinical and environmental factors for association with IBD-related surgery as the primary outcome variable.

Results

A multi-factor model was identified that yielded the highest predictive accuracy for need for surgery. The factors included in the model were the NOD2 genotype (OR = 1.607, P = 2.3 × 10−5), having ever had perianal disease (OR = 2.847, P = 4 × 10−6), being post-diagnosis smokers (OR = 6.312, P = 7.4 × 10−3), being an ex-smoker at diagnosis (OR = 2.405, P = 1.1 × 10−3) and age (OR = 1.012, P = 4.4 × 10−3). Diagnostic testing for this multi-factor model produced an area under the curve of 0.681 (P = 1 × 10−4) and an odds ratio of 3.169, (95 % CI P = 1 × 10−4) which was higher than any factor considered independently.

Conclusions

The results of this study require validation in other populations but represent a step forward in the development of more accurate prognostic tests for clinicians to prescribe the most optimal treatment approach for complicated CD patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Economou M and Pappas G, ‘New global map of Crohn’s disease: genetic, environmental and socioeconomic correlations’, Inflamm Bowel Dis, 2008; 14, 709–720PubMedCrossRef Economou M and Pappas G, ‘New global map of Crohn’s disease: genetic, environmental and socioeconomic correlations’, Inflamm Bowel Dis, 2008; 14, 709–720PubMedCrossRef
2.
go back to reference Vermeire S, Assche V.G. and Rutgeerts P, ‘Review article: altering the natural history of Crohn’s disease—evidence for and against current therapies’, Aliment Pharm Therap, 2006; 25, 3–12 Vermeire S, Assche V.G. and Rutgeerts P, ‘Review article: altering the natural history of Crohn’s disease—evidence for and against current therapies’, Aliment Pharm Therap, 2006; 25, 3–12
3.
go back to reference Hanauer SB, ‘Crohn’s disease: step up or top down therapy’, Best Pract Res Clin Gastroenterol, 2003; 17, 131–137PubMedCrossRef Hanauer SB, ‘Crohn’s disease: step up or top down therapy’, Best Pract Res Clin Gastroenterol, 2003; 17, 131–137PubMedCrossRef
4.
go back to reference Roberts R.L., Topless R.K., Phillips-Green A.J., et al, ‘Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn’s disease’, Genes Immun, 2010; 11:351–356PubMedCrossRef Roberts R.L., Topless R.K., Phillips-Green A.J., et al, ‘Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn’s disease’, Genes Immun, 2010; 11:351–356PubMedCrossRef
5.
go back to reference Gearry R.B., Roberts R.L., Burt M.J, et al, ‘Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population based cohort’ Inflamm Bowel Dis, 2007;13:1220–1226 Gearry R.B., Roberts R.L., Burt M.J, et al, ‘Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population based cohort’ Inflamm Bowel Dis, 2007;13:1220–1226
6.
go back to reference Gearry R.B., Richardson A.K., Frampton C.M., et al, ‘Population-based cases control study of inflammatory bowel disease risk factors’ J Gastroenterol Hepatol 2010; 25:325–333PubMedCrossRef Gearry R.B., Richardson A.K., Frampton C.M., et al, ‘Population-based cases control study of inflammatory bowel disease risk factors’ J Gastroenterol Hepatol 2010; 25:325–333PubMedCrossRef
7.
go back to reference Gearry R.B., Richardson A, Frampton C.M, Collette J.A, Burt M.J., Chapman B.A, Barclay M.L, ‘High Incidence of Crohn’s disease in Canterbury, New Zealand: Results of an epidemiologic study’, Inflamm Bowel Dis, 2006;12:10,936–943 Gearry R.B., Richardson A, Frampton C.M, Collette J.A, Burt M.J., Chapman B.A, Barclay M.L, ‘High Incidence of Crohn’s disease in Canterbury, New Zealand: Results of an epidemiologic study’, Inflamm Bowel Dis, 2006;12:10,936–943
8.
go back to reference Nasir BF, Griffiths L, Nasir A et al, ‘Perianal disease combined with NOD2 genotype predicts need for IBD-related surgery in Crohn’s disease patients from a population-based cohort’, J Clin Gastroenterol, 2013 (In press) Nasir BF, Griffiths L, Nasir A et al, ‘Perianal disease combined with NOD2 genotype predicts need for IBD-related surgery in Crohn’s disease patients from a population-based cohort’, J Clin Gastroenterol, 2013 (In press)
9.
go back to reference Lakatos PL, Czegledi Z, Szamosi T, et al ‘Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease’, World J Gastroenterol, 2009;15(28):3504–3510PubMedCrossRef Lakatos PL, Czegledi Z, Szamosi T, et al ‘Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease’, World J Gastroenterol, 2009;15(28):3504–3510PubMedCrossRef
10.
go back to reference Tarant KM, Barclay ML, Frampton CMA, et al ‘Perianal disease predicts changes in Crohn’s disease phenotype—results of a population-based study of inflammatory bowel disease phenotype’, Am J Gastroenterol, 2008;103:3082–3093CrossRef Tarant KM, Barclay ML, Frampton CMA, et al ‘Perianal disease predicts changes in Crohn’s disease phenotype—results of a population-based study of inflammatory bowel disease phenotype’, Am J Gastroenterol, 2008;103:3082–3093CrossRef
11.
go back to reference Yang CH, Ding J, Gao Y, et al ‘Risk factors that predict the requirement of aggressive therapy among Chinese patients with Crohn’s disease’, J Dig Dis, 2011;12; 99–104PubMedCrossRef Yang CH, Ding J, Gao Y, et al ‘Risk factors that predict the requirement of aggressive therapy among Chinese patients with Crohn’s disease’, J Dig Dis, 2011;12; 99–104PubMedCrossRef
12.
go back to reference Cosnes J, Beaugerie L, Carbonnel F et al, ‘Smoking cessation and the course of Crohn’s disease: An intervention study’ Gastroenterology, 2001; 120;1093–1099PubMedCrossRef Cosnes J, Beaugerie L, Carbonnel F et al, ‘Smoking cessation and the course of Crohn’s disease: An intervention study’ Gastroenterology, 2001; 120;1093–1099PubMedCrossRef
13.
go back to reference Danese S, Sans M, Fiocchi C, ‘Inflammatory Bowel Disease: the role of environmental factors’, Autoimmun Rev, 2004;3:394–400PubMedCrossRef Danese S, Sans M, Fiocchi C, ‘Inflammatory Bowel Disease: the role of environmental factors’, Autoimmun Rev, 2004;3:394–400PubMedCrossRef
14.
go back to reference Wei S-C, Ni Y-H, Yang H-I et al, ‘A hospital-based study of clinical and genetic features of Crohn’s disease’, JFMA, 2011;110:600–606 Wei S-C, Ni Y-H, Yang H-I et al, ‘A hospital-based study of clinical and genetic features of Crohn’s disease’, JFMA, 2011;110:600–606
15.
go back to reference Bouguen G and Peyrin-Biroulet L, ‘Surgery for adult Crohn’s disease: what is the actual risk?’, Gut, 2011;60(9):1178–1181 Bouguen G and Peyrin-Biroulet L, ‘Surgery for adult Crohn’s disease: what is the actual risk?’, Gut, 2011;60(9):1178–1181
16.
go back to reference Ramadas A.V., Gunesh S., Thomas G.O. et al, ‘Natural history of Crohn’s disease population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates’, Gut, 2010;59:1200–1206PubMedCrossRef Ramadas A.V., Gunesh S., Thomas G.O. et al, ‘Natural history of Crohn’s disease population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates’, Gut, 2010;59:1200–1206PubMedCrossRef
17.
go back to reference Siegel C.A., Siegel L.S., Hyams J.S. et al, ‘Real-time tool to display the predicted disease course and treatment response for children with Crohn’s disease’, Inflamm Bowel Dis, 2011;17:30–38PubMedCrossRef Siegel C.A., Siegel L.S., Hyams J.S. et al, ‘Real-time tool to display the predicted disease course and treatment response for children with Crohn’s disease’, Inflamm Bowel Dis, 2011;17:30–38PubMedCrossRef
18.
go back to reference Lewis CM, Whitwell SCL, Forbes A et al., ‘Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn’s disease’, J Med Genet, 2007:1–16 Lewis CM, Whitwell SCL, Forbes A et al., ‘Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn’s disease’, J Med Genet, 2007:1–16
19.
go back to reference Manolio T.A, Collins F.S, Cox N.J et al, ‘Finding the missing heritability of complex diseases’, Nature, 2009;461:747–753 Manolio T.A, Collins F.S, Cox N.J et al, ‘Finding the missing heritability of complex diseases’, Nature, 2009;461:747–753
20.
go back to reference Weersma R.K., Stokkers P.C., van Bodegraven A.A, et al, ‘Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort’, Gut, 2009;58(3):388–95 Weersma R.K., Stokkers P.C., van Bodegraven A.A, et al, ‘Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort’, Gut, 2009;58(3):388–95
Metadata
Title
An Envirogenomic Signature Is Associated with Risk of IBD-Related Surgery in a Population-Based Crohn’s Disease Cohort
Authors
Bushra F Nasir
Lyn R Griffiths
Aslam Nasir
Rebecca Roberts
Murray Barclay
Richard B Gearry
Rodney A Lea
Publication date
01-09-2013
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 9/2013
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-013-2250-1

Other articles of this Issue 9/2013

Journal of Gastrointestinal Surgery 9/2013 Go to the issue